Human FABP2/I-FABP DuoSet ELISA, 15 Plate

Images

 

Product Details

Summary
Reactivity HuSpecies Glossary
Applications ELISA
Conjugate
Biotin

Order Details

Human FABP2/I-FABP DuoSet ELISA, 15 Plate Summary

Assay Type
Solid Phase Sandwich ELISA
Inter-Assay
See PDF Datasheet for details
Intra-Assay
See PDF Datasheet for details
Spike Recovery
See PDF Datasheet for details
Sample Volume
See PDF Datasheet for details
Gene
FABP2

Applications/Dilutions

Dilutions
  • ELISA
Application Notes
No significant interference observed with available related molecules.
Publications
Read Publications using DY3078.

Packaging, Storage & Formulations

Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Human FABP2/I-FABP DuoSet ELISA, 15 Plate

  • FABP2
  • FABPI
  • fatty acid binding protein 2, intestinal
  • Fatty acid-binding protein 2
  • fatty acid-binding protein, intestinal
  • IFABP
  • I-FABP
  • I-FABPMGC133132
  • Intestinal FABP
  • Intestinal-type fatty acid-binding protein

Background

Fatty acid binding proteins are small cytoplasmic lipid binding proteins that are expressed in a tissue specific manner. FABPs bind free fatty acids, cholesterol, and retinoids, and are involved in intracellular lipid transport. Circulating FABP levels are used as indicators of tissue damage. Some FABP polymorphisms have been associated with disorders of lipid metabolism and the development of atherosclerosis.

FABP2, also known as intestinal fatty acid binding protein (I-FABP or FABPI) and gut FABP (gFABP), is a member of the cytosolic fatty acid binding protein family. FABP2 mediates the absorption and intracellular transport of dietary long-chain fatty acids. Genetic variations of FABP2 are implicated in obesity and Type II diabetes. Human FABP2 shares 78%, 82%, and 86% amino acid sequence identity with mouse, rat, and canine FABP2, respectively.

Customers Who Viewed This Item Also Viewed...

AF3166
Species: Hu
Applications: IHC, Simple Western, WB
NBP1-87695
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
MAB1417
Species: Bv, Hu, Mu
Applications: CyTOF-ready, ICC, IHC, ICFlow
AF1476
Species: Hu, Mu, Rt
Applications: IHC, KO, Simple Western, WB
MAB1678
Species: Hu, Mu, Rt
Applications: IHC, Simple Western, WB
D6050
Species: Hu
Applications: ELISA
AF3880
Species: Hu
Applications: ICC, WB
DCRP00
Species: Hu
Applications: ELISA
DLP00
Species: Hu
Applications: ELISA
NB100-2564
Species: Hu
Applications: WB
NBP2-01743
Species: Hu
Applications: Flow, ICC/IF, IHC, IHC-P, WB
NBP2-22106
Species: Hu, Mu, Rt
Applications: IHC, IHC-P, IP, WB
NB600-610
Species: Bv, Hu
Applications: ELISA, ICC/IF, IHC, IHC-P, IP, WB
NBP2-34294
Species: Hu, Mu, Rt
Applications: Flow, IHC, IHC-P
NBP1-62489
Species: Dr, Hu, Mu
Applications: WB
AF1443
Species: Mu, Rt
Applications: ICC, IHC, Simple Western, WB
AF7197
Species: Hu, Mu
Applications: ICC, IHC, WB
NB300-537
Species: Bv, Hu, Mu, Rb, Rt
Applications: ChIP, Flow, GS, ICC/IF, IHC, IHC-P, IP, KD, WB

Publications for FABP2/I-FABP (DY3078)(20)

We have publications tested in 1 confirmed species: Human.


Filter By Application
All Applications
Filter By Species
Human
(19)
All Species
Showing Publications 1 - 10 of 20. Show All 20 Publications.
Publications using DY3078 Applications Species
J Araújo Fiu, S Colt, L Gambogi de, L Ferreira M, A Gazzinelli, JF Friedman, R Corrêa-Oli The role of environmental enteric dysfunction in the pathogenesis of Schistosoma mansoni-associated morbidity in school-aged children PloS Neglected Tropical Diseases, 2022;16(10):e0010837. 2022 [PMID: 36197916] (Human) Human
AI Amaruddin, JPR Koopman, M Muhammad, K Lenaerts, HMH van Eijk, EAT Brienen, AR Geelen, L van Liesho, S Wahyuni, EJ Kuijper, RD Zwittink, F Hamid, E Sartono, M Yazdanbakh Intestinal permeability before and after albendazole treatment in low and high socioeconomic status schoolchildren in Makassar, Indonesia Scientific Reports, 2022;12(1):3394. 2022 [PMID: 35233023] (Human) Human
GR Ferreira, JR Santos-Oli, ML Silva-Frei, M Honda, DL Costa, AM Da-Cruz, CHN Costa Biomarkers of disease severity in patients with visceral leishmaniasis co-infected with HIV Cytokine, 2021;149(0):155747. 2021 [PMID: 34715475] (Human) Human
OE Asowata, A Singh, A Ngoepe, N Herbert, R Fardoos, K Reddy, Y Zungu, F Nene, N Mthabela, D Ramjit, F Karim, K Govender, T Ndung'u, JZ Porterfiel, JH Adamson, FG Madela, VT Manzini, F Anderson, A Leslie, HN Kløverpris Irreversible depletion of intestinal CD4+ T-cells is associated with T-cell activation during chronic HIV infection JCI Insight, 2021;0(0):. 2021 [PMID: 34618690] (Human) Human
A Nuzzo, K Guedj, S Curac, C Hercend, C Bendavid, N Gault, A Tran-Dinh, M Ronot, A Nicoletti, Y Bouhnik, Y Castier, O Corcos, K Peoc'h, SURVI (Str Accuracy of citrulline, I-FABP and D-lactate in the diagnosis of acute mesenteric ischemia Scientific Reports, 2021;11(1):18929. 2021 [PMID: 34556697] (Human) Human
Tominaga T, Ikemura T, Yada K, Kanda K, Sugama K, Ma S, Choi W, Araya M, Huang J, Nakamura N, Suzuki K The Effects of Beverage Intake after Exhaustive Exercise on Organ Damage, Inflammation and Oxidative Stress in Healthy Males. Antioxidants (Basel), 0;10(6):. 0 [PMID: 34071378] (Human) Human
R Fernandez-, MW Plankey, D Ware, J Bordon Changes in liver steatosis in HIV-positive women are associated with the BMI, but not with biomarkers Cytokine, 2021;0(0):155573. 2021 [PMID: 33994069] (Human) Human
S Novelli, C Lécuroux, C Goujard, J Reynes, A Villemant, L Blum, A Essat, V Avettand-F, O Launay, JM Molina, C Bourgeois, L Meyer Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection EBioMedicine, 2020;62(0):103129. 2020 [PMID: 33248370] (Human) Human
R Laatikaine, H Salmenkari, T Sibakov, H Vapaatalo, A Turpeinen Randomised Controlled Trial: Partial Hydrolysation of Casein Protein in Milk Decreases Gastrointestinal Symptoms in Subjects with Functional Gastrointestinal Disorders Nutrients, 2020;12(7):. 2020 [PMID: 32708428] (Human) Human
I Vujkovic-C, O Sortino, E Verheij, J Sklar, FW Wit, NA Kootstra, B Sellers, JM Brenchley, J Ananworani, MSV Loeff, Y Belkaid, P Reiss, I Sereti HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases Nat Commun, 2020;11(1):2448. 2020 [PMID: 32415070] (Human) Human
Show All 20 Publications.

Reviews for FABP2/I-FABP (DY3078) (0)

There are no reviews for FABP2/I-FABP (DY3078). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for FABP2/I-FABP (DY3078) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Review this Product

Be the first to review our Human FABP2/I-FABP DuoSet ELISA, 15 Plate and receive a gift card or discount.

Bioinformatics

Gene Symbol FABP2